|
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? |
Nov 2020 |
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
|
Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. |
Feb 2019 |
Cancer Med |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Family reflections: pediatric aplastic anemia research; a parent perspective |
Oct 2024 |
Pediatric Research |
Aplastic Anemia, Pediatric |
|
Family reflections: George Elliott: a first-person commentary on pediatric aplastic anemia research |
Aug 2024 |
Pediatric Research |
Aplastic Anemia |
|
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria |
Jul 2023 |
Blood Reviews |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials |
May 2024 |
Current Medical Research and Opinion |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria |
Mar 2024 |
Hematology. |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
Dec 2023 |
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
|
Existing agents, novel agents, or transplantation for high-risk MDS |
Dec 2020 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Evolving therapies for lower-risk myelodysplastic syndromes |
Apr 2020 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
